Skip to Content
Skip to Content

Substance evaluation - CoRAP

Substance evaluation - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 28 July 2020. Database contains 382 unique substances/entries.
Filter the list
Initial grounds for concern:

 
287-477-0
85535-85-9
2012
United Kingdom
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
412-780-3
-
France
Suspected PBT/vPvB
Concluded
Details
247-156-8
25640-78-2
Germany
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
253-242-6
36861-47-9
2020
Germany
Potential endocrine disruptor
Ongoing
Details
241-867-7
17928-28-8
2021
Norway
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
217-496-1
1873-88-7
2021
Norway
Suspected PBT/vPvB
Not started
Details
202-773-1
99-62-7
2021
Bulgaria
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
202-826-9
100-18-5
2021
Bulgaria
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
EC No. 216-133-4 and EC No. 244-240-6
show/hide
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 216-133-4 | CAS no: 1506-02-1
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 244-240-6 | CAS no: 21145-77-7
-
-
2020
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Ongoing
Details
701-029-8
-
Estonia
CMR
Sensitiser
Consumer use
Wide dispersive use
Withdrawn
Details
700-604-0
947701-81-7
Finland
Suspected PBT/vPvB
Consumer use
Withdrawn
Details
253-057-0
36483-57-5
2022
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Not started
Details
622-542-2
3891-98-3
2021
Austria
Suspected Mutagenic
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Not started
Details
226-866-1
5521-31-3
2022
Belgium
Suspected PBT/vPvB
Not started
Details
200-076-7
51-03-6
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Withdrawn
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
2022
France
Suspected Mutagenic
Potential endocrine disruptor
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
248-227-6
27107-89-7
2022
Netherlands
Potential endocrine disruptor
Not started
Details
204-263-4
118-60-5
2022
Germany
Potential endocrine disruptor
Not started
Details
202-627-7
98-01-1
2022
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
221-975-0
3302-10-1
2021
Spain
Suspected Reprotoxic
Exposure of workers
Not started
Details
200-657-5
67-51-6
2021
Spain
Reprotoxic
High RCR
Not started
Details
242-016-2
18127-01-0
2022
Sweden
Suspected Reprotoxic
Not started
Details
432-520-2
232938-43-1
2022
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Not started
Details
209-711-2
591-27-5
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Ongoing
Details
264-727-7
64194-22-5
Slovenia
Suspected Carcinogenic
Exposure of workers
Wide dispersive use
Withdrawn
Details
204-633-5
123-51-3
2021
Poland
Suspected Carcinogenic
Suspected Reprotoxic
Suspected Sensitiser
Consumer use
Exposure of workers
Not started
Details
233-593-1
10254-57-6
2021
Germany
Suspected PBT/vPvB
Not started
Details
701-276-1
-
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
405-520-5
95235-30-6
2021
Belgium
Potential endocrine disruptor
Other exposure/risk based concern
Not started
Details
204-616-2
123-30-8
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Ongoing
Details
220-618-6
2835-95-2
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Ongoing
Details
400-370-7
-
2021
Finland
Suspected PBT/vPvB
Exposure of environment
Not started
Details
251-020-3
32388-55-9
2022
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Not started
Details
421-820-9
192268-65-8
2022
Netherlands
Suspected PBT/vPvB
Not started
Details
283-044-5
84539-55-9
2021
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
247-118-0
25584-83-2
2022
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Not started
Details
931-292-6
308062-28-4
2021
Ireland
Suspected Reprotoxic
Other hazard based concern
Not started
Details
225-935-3
5160-02-1
2020
Germany
Suspected Carcinogenic
Exposure of workers
Wide dispersive use
Ongoing
Details
202-860-4
100-52-7
2021
France
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Not started
Details
204-262-9
118-58-1
2022
Germany
Potential endocrine disruptor
Not started
Details
931-700-2
-
2022
France
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
218-487-5
2162-74-5
2021
Italy
Suspected PBT/vPvB
Exposure of workers
Wide dispersive use
Not started
Details
203-090-1
103-23-1
2020
Finland
Suspected CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
258-469-4
53306-54-0
2020
Germany
Potential endocrine disruptor
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
200-237-1
55-55-0
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Ongoing
Details
237-695-7
13927-71-4
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of workers
Ongoing
Details
253-249-4
36878-20-3
2021
France
Suspected Mutagenic
Suspected PBT/vPvB
High (aggregated) tonnage
Not started
Details
245-366-4
22984-54-9
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
218-747-8
2224-33-1
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
215-609-9
1333-86-4
2022
France
Carcinogenic
Suspected Reprotoxic
Consumer use
Cumulative exposure
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
215-150-4
1306-38-3
2021
Germany
Suspected Carcinogenic
Suspected Mutagenic
Other hazard based concern
Cumulative exposure
Exposure of environment
Wide dispersive use
Not started
Details
200-467-2
60-29-7
2022
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
233-072-9
10028-22-5
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
246-835-6
25321-09-9
2021
France
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
214-189-4
1112-39-6
2022
Belgium
Reprotoxic
Other hazard based concern
Exposure of workers
Not started
Details
234-126-4
10544-72-6
Latvia
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High RCR
Withdrawn
Details
212-791-1
870-08-6
2021
Austria
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
278-355-8
75980-60-8
2022
Sweden
Reprotoxic
Potential endocrine disruptor
Not started
Details
205-117-2
133-66-4
Italy
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
405-420-1
-
2021
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
941-303-6
-
2022
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Not started
Details
609-946-4
41637-38-1
2021
Germany
Suspected PBT/vPvB
Exposure of environment
Not started
Details
204-399-4
120-47-8
2021
Germany
Potential endocrine disruptor
Not started
Details
272-902-4
68919-76-6
2021
Germany
Suspected PBT/vPvB
Exposure of environment
Not started
Details
701-057-0
-
2021
Germany
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Not started
Details
938-828-8
-
2021
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
249-535-3
29253-36-9
Austria
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
629-767-5
1228186-18-2
2021
Germany
Exposure of environment
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
202-870-9
100-61-8
2022
Poland
Suspected Carcinogenic
Suspected Mutagenic
Cumulative exposure
Exposure of workers
High RCR
Wide dispersive use
Not started
Details
220-260-0
2691-41-0
2021
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
The complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isononanal. It consists predominantly of C6 olefins and paraffins and C9 alcohols and aldehydes and boiling in the range of approximately 110°C to 202°C (230°F to 396°F).
273-110-1
68938-03-4
2022
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Not started
Details
271-846-8
68609-97-2
2022
Ireland
Suspected Mutagenic
Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Not started
Details
225-716-2
5026-74-4
2022
Denmark
Suspected Mutagenic
Suspected Sensitiser
Consumer use
Exposure of workers
Not started
Details
206-420-2
338-83-0
2020
Belgium
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
204-500-1
121-82-4
2021
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
201-344-6
81-33-4
2022
Belgium
Suspected PBT/vPvB
Not started
Details
273-066-3
68937-41-7
2020
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Ongoing
Details
203-686-1
109-60-4
2022
Ireland
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
701-241-0, 906-390-7
-
2022
Italy
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
905-562-9
-
2021
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
905-588-0
-
2021
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
204-857-3
127-68-4
2022
Ireland
Suspected Reprotoxic
Other hazard based concern
Exposure of workers
High (aggregated) tonnage
Not started
Details
205-739-4
149-44-0
2022
Netherlands
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
260-830-6
57583-54-7
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
203-929-1
112-03-8
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
237-159-2
13674-87-8
2021
Germany
Potential endocrine disruptor
Not started
Details
215-535-7
1330-20-7
2021
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
229-782-3
6731-36-8
2014
Germany
Suspected PBT/vPvB
Ongoing
Details
203-308-5
105-55-5
2019
Poland
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Conclusion under preparation
Details
219-372-2
2425-85-6
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Conclusion under preparation
Details
222-429-4
3468-63-1
2019
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Wide dispersive use
Conclusion under preparation
Details
220-562-2
2814-77-9
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Conclusion under preparation
Details
216-475-4
1594-08-7
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
202-707-1
98-85-1
2019
Italy
Suspected Carcinogenic
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Ongoing
Details
627-872-0
1514-82-5
2019
Spain
Suspected Reprotoxic
Potential endocrine disruptor
Conclusion under preparation
Details
201-618-5
85-60-9
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
203-372-4
106-20-7
2019
Portugal
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
201-247-9
80-07-9
2019
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
show/hide
Tangled Multi-Walled Carbon Nanotubes EC / List no: 701-160-0 | CAS no: -
-
-
2019
Germany
Suspected Carcinogenic
Other hazard based concern
Consumer use
Cumulative exposure
Exposure of environment
Wide dispersive use
Conclusion under preparation
Details
223-055-4
3710-84-7
2019
Sweden
Suspected Carcinogenic
Suspected Mutagenic
Ongoing
Details
219-006-1
2312-35-8
2019
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Conclusion under preparation
Details
202-924-1
101-20-2
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Wide dispersive use
Conclusion under preparation
Details
203-545-4
108-05-4
2019
Latvia
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
284-366-9
84852-53-9
2012
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
306-832-3
97416-84-7
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
244-617-5
21850-44-2
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
203-820-9
110-97-4
2013
Czech Republic
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
213-668-5
999-97-3
2014
Spain
High (aggregated) tonnage
High RCR
Concluded
Details
271-085-1
68515-43-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Ongoing
Details
203-812-5
110-88-3
2013
Poland
Suspected CMR
Suspected PBT/vPvB
Suspected Sensitiser
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
211-463-5
646-06-0
2016
Germany
Suspected Mutagenic
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
204-077-3
115-27-5
2013
France
CMR
Suspected PBT/vPvB
Suspected Sensitiser
Exposure of environment
Exposure of workers
Information requested
Details
627-083-1
244235-47-0
2015
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
274-581-6
70356-09-1
2015
Germany
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
203-049-8
102-71-6
2014
United Kingdom
Suspected CMR
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
926-564-6
-
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
203-872-2
111-46-6
2015
Hungary
Suspected CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
201-236-9
79-94-7
2015
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
204-279-1
118-82-1
2014
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Information requested
Details
247-979-2
26761-45-5
2015
Denmark
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
218-645-3
2210-79-9
2016
Denmark
Mutagenic
Information requested
Details
211-989-5
732-26-3
2017
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
204-278-6
118-79-6
2012
Norway
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-614-9
108-77-0
2017
Poland
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Concluded
Details
202-532-0
96-76-4
2017
Belgium
Suspected CMR
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
201-222-2
79-74-3
2014
Italy
Suspected PBT/vPvB
High RCR
Follow-up
Details
204-881-4
128-37-0
2016
France
Potential endocrine disruptor
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
201-289-8
80-54-6
2012
Sweden
CMR
Consumer use
Wide dispersive use
Ongoing
Details
405-490-3
613-62-7
2012
Czech Republic
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
266-733-5
67584-55-8
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Concluded
Details
205-483-3
141-43-5
2014
United Kingdom
Suspected Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
239-701-3
15625-89-5
2014
France
Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
203-234-3
104-76-7
2014
Poland
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
205-743-6
149-57-5
2012
Spain
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
260-828-5
57583-34-3
2015
Netherlands
CMR
High (aggregated) tonnage
Suspended
Details
629-661-9
83834-59-7
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
241-527-8
17527-29-6
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Information requested
Details
218-407-9
2144-53-8
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Information requested
Details
201-126-0
78-59-1
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
435-790-1
297730-93-9
2018
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
201-052-9
77-73-6
2016
France
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
High RCR
Ongoing
Details
428-970-4
13595-25-0
2014
Belgium
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Concluded
Details
253-781-7
38103-06-9
2013
Germany
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
201-250-5
80-09-1
2014
Belgium
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
202-966-0
101-68-8
2013
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Concluded
Details
203-253-7
104-93-8
2012
Ireland
CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
202-679-0
98-54-4
2014
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Ongoing
Details
202-653-9
98-29-3
2018
Poland
Suspected Mutagenic
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Exposure of environment
Exposure of workers
Concluded
Details
204-327-1
119-47-1
2016
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Concluded
Details
202-525-2
96-69-5
2015
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Information requested
Details
246-678-3
25155-25-3
2015
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
422-040-1
426218-78-2
2016
Spain
Suspected PBT/vPvB
Exposure of environment
High RCR
Information requested
Details
405-040-6
63500-71-0
2012
Spain
High RCR
Wide dispersive use
Concluded
Details
231-208-1
7446-70-0
2015
France
Suspected CMR
Exposure of workers
High (aggregated) tonnage
High RCR
Information requested
Details
700-242-3
62037-80-3
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
700-323-3
908020-52-0
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
232-235-1
7790-98-9
2015
Germany
Suspected Carcinogenic
Potential endocrine disruptor
Other hazard based concern
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
700-403-8
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Ongoing
Details
232-565-6
9000-90-2
2015
United Kingdom
Sensitiser
Consumer use
Exposure of workers
Concluded
Details
233-047-2
10025-91-9
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Concluded
Details
270-128-1
68411-46-1
2016
Germany
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
284-660-7
84961-70-6
2014
Italy
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
810-801-4
-
2015
Netherlands
Suspected CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
204-337-6
119-61-9
2013
Denmark
Suspected CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
205-736-8
149-30-4
2013
Germany
CMR
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
231-150-7
7440-41-7
2013
Germany
Other exposure/risk based concern
Concluded
Details
421-450-8
154702-15-5
2015
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
247-426-5
26040-51-7
2019
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Conclusion under preparation
Details
254-052-6
38640-62-9
2013
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
243-001-3
19372-44-2
2015
Germany
Sensitiser
Other hazard based concern
Exposure of workers
High (aggregated) tonnage
Ongoing
Details
203-450-8
106-99-0
2014
Germany
CMR
Other exposure/risk based concern
Concluded
Details
200-751-6
71-36-3
2017
Hungary
Suspected Reprotoxic
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-496-6
96-29-7
2013
Germany
CMR
Sensitiser
Consumer use
Cumulative exposure
High RCR
Wide dispersive use
Concluded
Details
205-480-7
141-32-2
2013
Sweden
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
700-992-1
-
2014
Norway
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
200-843-6
75-15-0
2013
France
CMR
Potential endocrine disruptor
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Follow-up
Details
253-775-4
38083-17-9
2014
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Information requested
Details
203-631-1
108-94-1
2016
Poland
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
205-016-3
131-17-9
2013
Spain
CMR
Consumer use
Wide dispersive use
Concluded
Details
200-838-9
75-09-2
2016
Italy
Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
High (aggregated) tonnage
Ongoing
Details
DCHP
201-545-9
84-61-7
2017
Sweden
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Information requested
Details
270-877-4
68479-98-1
2016
Denmark
Suspected Mutagenic
Suspected Reprotoxic
Ongoing
Details
214-277-2
1119-40-0
2014
Poland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
215-575-5
1332-77-0
2017
Lithuania
Reprotoxic
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
229-912-9
6834-92-0
2015
Latvia
Suspected Reprotoxic
Consumer use
High (aggregated) tonnage
High RCR
Concluded
Details
248-948-6
28299-41-4
2014
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Follow-up
Details
205-492-2
141-63-9
2015
Norway
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
202-510-0
96-49-1
2018
Latvia
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
200-001-8
50-00-0
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-492-7
107-46-0
2013
Norway
Suspected CMR
Consumer use
High (aggregated) tonnage
Information requested
Details
206-019-2
288-32-4
2012
United Kingdom
CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
931-745-8
-
2014
Sweden
Suspected PBT/vPvB
Exposure of environment
High RCR
Ongoing
Details
275-702-5
71617-10-2
2016
Germany
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
201-202-3
79-39-0
2016
Sweden
Other hazard based concern
Exposure of workers
Information requested
Details
200-659-6
67-56-1
2012
Poland
Suspected CMR
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
201-297-1
80-62-6
2014
France
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
204-317-7
119-36-8
2015
France
Suspected CMR
Consumer use
High (aggregated) tonnage
Follow-up
Details
448-020-2
-
2013
Slovakia
CMR
Suspected PBT/vPvB
High RCR
Concluded
Details
700-427-9
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
201-983-0
90-30-2
2012
Germany
Suspected PBT/vPvB
Wide dispersive use
Information requested
Details

Export search results to:

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live2